Corporate Action / Merger
Torrent Pharma Fixes Record Date for Amalgamation with JB Chemicals
NSE
TORNTPHARM
BSE
500420
Torrent Pharmaceuticals Limited has announced 17 July 2026 as the record date for determining eligible shareholders of JB Chemicals & Pharmaceuticals Limited who will receive Torrent Pharma shares under the approved Scheme of Amalgamation.
PRICE-SENSITIVE TRIGGER
Event: Record Date Fixed for Scheme of Amalgamation
Type: Corporate Action / Merger
Impact: Positive
Immediate Effect: JB Chemicals shareholders holding shares as of the record date will become eligible to receive Torrent Pharma equity shares according to the approved exchange ratio, marking another implementation milestone in the merger process.
Key Metrics:
- Record Date: 17 July 2026
- Share Exchange Ratio: 51 Torrent Pharma equity shares for every 100 JB Chemicals equity shares
- Torrent Pharma Face Value: ₹5 per share
- JB Chemicals Face Value: ₹1 per share
Highlight:
- Record date fixed for implementation of the NCLT-approved amalgamation scheme.
What Happened ?
Torrent Pharmaceuticals informed the stock exchanges that, pursuant to the NCLT Ahmedabad Bench’s order dated 6 July 2026, it has fixed 17 July 2026 as the record date for determining eligible shareholders of JB Chemicals & Pharmaceuticals Limited who will receive Torrent Pharma equity shares under the approved Scheme of Amalgamation.
The announcement follows the company’s earlier disclosures made on 6 July 2026 and 7 July 2026 regarding the merger.
Key Details
Key Points:
- Record date fixed as Friday, 17 July 2026.
- Applicable to shareholders of JB Chemicals & Pharmaceuticals Limited.
- The Scheme of Amalgamation has been sanctioned by the Hon’ble National Company Law Tribunal (NCLT), Ahmedabad Bench.
- Eligible shareholders will receive:
- 51 fully paid-up Torrent Pharma equity shares (Face Value ₹5 each)
- For every 100 fully paid-up JB Chemicals equity shares (Face Value ₹1 each).
- The record date will determine shareholder eligibility for receiving Torrent Pharma shares under the approved scheme.
Note:
- This announcement relates to the implementation of the already approved amalgamation and does not alter the previously announced exchange ratio.
Risk Analysis
Summary:
- The disclosure is primarily an implementation update and does not introduce any new financial obligations or changes to the approved merger terms.
Key Risks:
- Completion of the amalgamation remains subject to execution of the approved scheme.
- Shareholders not holding JB Chemicals shares on the record date will not qualify for share allotment.
- Successful post-merger integration remains important for realizing expected synergies.
Worst Case:
- Unexpected implementation or administrative delays could postpone completion of the amalgamation process.
Risk Level: Low
Company Commentary
- Record date fixed as 17 July 2026 in consultation with JB Chemicals.
- The Scheme of Amalgamation has been approved by the NCLT Ahmedabad Bench.
- Eligible shareholders will receive Torrent Pharma shares based on the approved 51:100 exchange ratio.
- The announcement is issued under Regulation 42 read with Regulation 30 of the SEBI (LODR) Regulations, 2015.
Official Exchange Filing: Torrent Pharmaceuticals Limited
